Skip to main content

Market Overview

Benzinga's M&A Chatter for Tuesday December 1, 2015

Share:

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday December 1, 2015:

Chatter of Potential Amgen Bid for Clovis

The Rumor:
Shares of Clovis Oncology (NASDAQ: CLVS) surged higher Tuesday, on unconfirmed market chatter of a potential bid from Amgen (NASDAQ: AMGN), according to sources. Shares rose as high $33.20 following the report.

Spokespersons for Amgen and Clovis were not available for comment.

Clovis shares rose 1.91% Tuesday, closing at $32.05.

Air Products Not Pursuing Bid for AirGas

The CEO Comments:
Air Products and Chemicals, Inc. (NYSE: APD) CEO Seifi Ghasemi, said at a conference on Tuesday, that the company "will not pursue a bid to acquire Airgas (NYSE: ARG)." Air Liquide had announced on November 17 that it was acquiring Air Gas for $143 per share in cash.

APD had offered $60 per share for AirGas in 2010.

Airgas rose $0.10 Tuesday, closing at $138.30.

Perion Networks Acquires Undertone for $180M in Enterprise Value

The Deal:
Perion Network Ltd. (NASDAQ: PERI) announced Tuesday, that it has acquired cross-screen advertising solutions provider, Undertone, for $180 million in total enterprise value. The deal is all-cash and will be financed with approximately $91 million in cash from Perion, $16 million as a holdback, payable in 18 months, $3 million payable in installments over the next 18 months, plus $20 million, bearing interest, due in 2020.

Perion closed at $2.40 Tuesday, up 8.6%.

 

Related Articles (AMGN + APD)

View Comments and Join the Discussion!

Posted-In: M&A News Rumors Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com